Target, Home Depot,...
Health Care: Drugs
Impax Laboratories Inc. (IPXL: NASDAQ)
$18.42 -0.22 | -1.18%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 18.42 |
| 52 Week High | 27.25 |
| 52 Week Low | 14.41 |
| Avg. Daily Vol. (Mil) | 1.22 |
| Beta (3 year) | 0.81 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,261.35 |
| Shares Out (Mil) | 68.48 |
| Float (Mil) | 63.54 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.20 |
| Current Ratio | 3.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 8.40 |
| Price/Sales | 2.10 |
| Price/Book | 1.58 |
| Price/Cash Flow | 5.10 |
| Per Share Data | |
| Earnings | 2.18 |
| Sales | 8.79 |
| Book Value | 11.66 |
| Cash Flow | 3.59 |
| Business Summary | |
|---|---|
| Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development. | |
| General Information | |
| 30831 Huntwood Avenue
Hayward, CA 94544 |
|
| www.impaxlabs.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1125 | |
| CEO: Dr. Larry Hsu,PhD | |
| Short Interest | |
| Current Month (Mil) | 2.99 |
| Previous Month (Mil) | 2.74 |
| Short Interest Ratio (Days) | 4.00 |
| Management Effectiveness | |
| Return on Equity | 18.70 |
| Return on Assets | 14.80 |
| Return on Investments | 18.70 |
| Profitability | |
| Gross Margin | 62.30 |
| EBIT Margin | 36.50 |
| Profit Margin | 24.80 |
Portfolios with IPXL
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- UserOwn Now
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- Contributor8 Pharma Stocks to Watch
- Contributor5 Bargain Biotech Stocks
Latest IPXL Headlines from TheStreet
- Impax Laboratories Inc. Stock Downgraded (IPXL) 05.03.13 | 05:05 am
- 3 Stocks Spiking on Big Volume 04.03.13 | 03:04 pm
- The 5 Dumbest Things on Wall Street: March 8
03.08.13 | 11:03 am - The 5 Dumbest Things on Wall St. This Week: March 8 03.08.13 | 07:03 am
- 4 Stocks Spiking on Unusual Volume 03.07.13 | 08:03 am
- Dow Closes at Record High 03.05.13 | 04:03 pm
- Stock Futures Trace Gains in Overseas Markets 03.05.13 | 09:03 am
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
- Analysts' Actions: FB HPQ MAR GPS ZNGA 10.05.12 | 09:10 am
- 8 Stocks Rising on Big Volume 09.19.12 | 02:09 pm
Press Releases for IPXL
- UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Impax Laboratories Inc. Of Class Action Lawsuit And The Deadline Of May 6, 2013 To Seek A Lead Plaintiff Position - PR Newswire 04.23.13 | 03:04 pm
- Pittsburgh Law Office Of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf Of Shareholders Of Tangoe (TNGO) And Announces Investigations Of Atlantic Power Corp. (AT), Bazaarvoice (BV), Boeing (BA), Caterpillar (CAT), Diodes (DIOD), Harvest Natural Resources (HNR), Hess Corp. (HES), Impax Laboratories ( IPXL), Incyte Corp. (INCY), ITT Educational Services (ESI), - PR Newswire 04.12.13 | 07:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Impax Laboratories, Inc. To Contact The Firm - PR Newswire 03.29.13 | 09:03 pm
- Impax Pharmaceuticals Announces Presentation Of RYTARYTM (IPX066) (Carbidopa And Levodopa) Extended-Release Capsules Phase III And Open-Label Extension Data At The American Academy Of Neurology 2013 Annual Meeting - Business Wire 03.19.13 | 08:03 am
- Lifshitz Law Firm Announces Class Action Lawsuits Against Affymax, Inc., Impax Laboratories Inc., And Tangoe, Inc. - PR Newswire 03.18.13 | 07:03 pm
- RYTARYTM (IPX066) (Carbidopa And Levodopa) Extended-Release Capsules Phase III And Open-Label Extension Data To Be Presented At The American Academy Of Neurology Conference - Business Wire 03.15.13 | 08:03 am
- Impax Laboratories, Inc. Continues To Ignore FDA Warnings, Causing A Delay In Bringing A New Drug To Market; Robbins Arroyo LLP Investigates On Behalf Of Impax Shareholders - PR Newswire 03.14.13 | 06:03 pm
- Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Impax Laboratories Inc. - PR Newswire 03.14.13 | 08:03 am
- Impax Laboratories Shareholder Alert: Briscoe Law And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors - Business Wire 03.08.13 | 03:03 pm
- Finkelstein Thompson LLP Announces Investigation Of Impax Laboratories, Inc. - Business Wire 03.07.13 | 04:03 pm
Partner Headlines for IPXL
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? - Seeking Alpha 04.04.13 | 09:04 am
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- Warner Chilcott Tops, View Raised - Analyst Blog - Zacks 11.15.12 | 09:11 am
- Reel In Price Target, Sell Rules In Rough Market - Investor's Business Daily 11.05.12 | 05:11 pm
- Stocks Near Highs In Late Trading; PVH At Record High - Investor's Business Daily 11.01.12 | 02:11 pm
- Stocks Saw Late Buying, But Gains Couldn't Stick - Investor's Business Daily 10.31.12 | 04:10 pm
- Stocks Shake Off Losses; Cirrus Reports After Close - Investor's Business Daily 10.31.12 | 03:10 pm
- Stocks Open Mixed; PVH, Warnaco Group Soar On Merger - Investor's Business Daily 10.31.12 | 10:10 am
- Hurricane Sandy Shuts In Market For Second Day - Investor's Business Daily 10.30.12 | 09:10 am
- Shire Misses on All Fronts - Analyst Blog - Zacks 10.29.12 | 10:10 am
